| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Division of Allergy and Immunology, Montreal Children’s Hospital, McGill University/Montreal Children’s Hospital Research Institute, and
Meakins Christie Laboratories, McGill University, Montreal, Quebec, Canada
Although platelet-activating factor (PAF) receptors have been found on B lymphoblastoid cell lines, the action of PAF on freshly isolated human B cells has not been clearly demonstrated. Using a sensitive semiquantitative reverse-transcriptase PCR, we have found PAF receptor mRNA expressed by tonsillar B lymphocytes, but little in T lymphocytes. Examination of Percoll-fractionated tonsillar B cells indicated that the low density (primarily germinal center cells) and medium density fractions had approximately twofold more PAF receptor mRNA relative to the high density fraction. PAF (10-7 M) stimulated increases in intracellular Ca2+ that were consistently higher in the low and medium density B lymphocytes compared with high density cells. The PAF receptor antagonist Web 2170 inhibited this. Addition of PAF, but not lyso- or enantio-PAF, induced four- to sixfold greater synthesis of IgM and IgG in low and medium density cells compared with unstimulated controls, but had little effect on Ig production by high density cells. To investigate how PAF may influence Ig synthesis, PAF-stimulated B cells were examined for production of the Th2-type cytokines IL-4 and IL-13. PAF induced IL-4 and IL-13 mRNA expression in 17% of CD20+ cells, and IL-4 was detected in cell supernatants after 48–72 h of culture. Together, these data strongly suggest that functional PAF receptors are expressed on B cells in tonsils.
This article has been cited by other articles:
|
|
 |
|
  Y. Matsumura, S. N. Byrne, D. X. Nghiem, Y. Miyahara, and S. E. Ullrich A Role for Inflammatory Mediators in the Induction of Immunoregulatory B Cells J. Immunol., October 1, 2006; 177(7): 4810 - 4817. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Harris, S. Goodrich, K. Mohrs, M. Mohrs, and F. E. Lund Cutting Edge: The Development of IL-4-Producing B Cells (B Effector 2 Cells) Is Controlled by IL-4, IL-4 Receptor {alpha}, and Th2 Cells J. Immunol., December 1, 2005; 175(11): 7103 - 7107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Al-Darmaki, K. Knightshead, Y. Ishihara, A. Best, H. A. Schenkein, J. G. Tew, and S. E. Barbour Delineation of the Role of Platelet-Activating Factor in the Immunoglobulin G2 Antibody Response Clin. Vaccine Immunol., July 1, 2004; 11(4): 720 - 728. [Abstract] [Full Text]
|
|
|
|
|
|
B. Johansson-Lindbom, S. Ingvarsson, and C. A. K. Borrebaeck Germinal Centers Regulate Human Th2 Development J. Immunol., August 15, 2003; 171(4): 1657 - 1666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Donnard, L. Guglielmi, P. Turlure, C. Piguet, M.J. Couraud, D. Bordessoule, and Y. Denizot Membrane and Intracellular Platelet-Activating Factor Receptor Expression in Leukemic Blasts of Patients with Acute Myeloid and Lymphoid Leukemia Stem Cells, September 1, 2002; 20(5): 394 - 401. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Zhuang, Y. Bastien, and B. D. Mazer Activation Via Multiple Signaling Pathways Induces Down-Regulation of Platelet-Activating Factor Receptors on Human B Lymphocytes J. Immunol., September 1, 2000; 165(5): 2423 - 2431. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ishihara, J.-B. Zhang, S. M. Quinn, H. A. Schenkein, A. M. Best, S. E. Barbour, and J. G. Tew Regulation of Immunoglobulin G2 Production by Prostaglandin E2 and Platelet-Activating Factor Infect. Immun., March 1, 2000; 68(3): 1563 - 1568. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
